In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

BTIG analyst Vincent Caintic updated the firm's stance on American Express (NYSE:AXP) shares, raising the price target to ...

Papa Johns’ blueprint under CEO Todd Penegor has several targets, from core strength focus to data leverage to tech stack ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASHUA, N.H., Jan.

Ginkgo Bioworks Holdings Inc (DNA) stock saw a decline, ending the day at $12.82 which represents a decrease of $-0.36 or -2.73% from the prior close of $13.18. The stock opened at $13.32 and touched ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

In terms of valuation, Akebia Therapeutics Inc’s market capitalization stands at $519.27 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

SoFi (SOFI) surpassed analyst expectations in fourth quarter revenue and adjusted earnings per share (EPS), but its stock is ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target.